Research Funding
- NIH Director's Early Independence Award
- NIH Director's New Innovator Award
- NIH Director's Pioneer Award
- NIH Director's Transformative Research Award
- Illuminating the Druggable Genome Program
- Gabriella Miller Kids First Pediatric Research Program
- Somatic Cell Genome Editing (SCGE) Program
- Somatic Mosaicism across Human Tissues (SMaHT) Program
- NIH Faculty Institutional Recruitment for Sustainable Transformation
- Harnessing Data Science for Health Discovery and Innovation in Africa
High-Risk Research: NIH Director's Early Independence Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| NIH Directors Early Independence Awards (DP5 Clinical Trial Optional) | 4/27/2022 | RFA-RM-22-021 | Becky Miller earlyindependence@mail.nih.gov 301-594-9979 |
Letter of Intent: 8/2/2022 Receipt Date: 9/2/2022 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-21-071 | Becky Miller earlyindependence@mail.nih.gov 301-594-9979 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Becky Miller earlyindependence@mail.nih.gov 301-594-9979 |
High-Risk Research: NIH Director's New Innovator Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional) | 4/7/2022 | RFA-RM-22-019 | Patricia (Trish) Labosky 301-594-4863 | Receipt date: 8/19/2022 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-21-071 | Ravi Basavappa NewInnovatorAward@mail.nih.gov (301) 435-7204 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Ravi Basavappa NewInnovatorAward@mail.nih.gov 301 435-7204 |
High-Risk Research: NIH Director's Pioneer Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| 2023 NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional) | 4/13/2022 | RFA-RM-22-018 | Ravi Basavappa PioneerAwards@mail.nih.gov (301) 435-7204 |
9/9/2022 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-21-071 | Ravi Basavappa PioneerAwards@mail.nih.gov (301) 435-7204 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Ravi Basavappa PioneerAwards@mail.nih.gov 301 435-7204 |
High-Risk Research: NIH Director's Transformative Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) | 5/12/2022 | RFA-RM-22-020 | Ravi Basavappa Transformative_Awards@mail.nih.gov (link sends e-mail) (301) 435-7204 |
9/1/2022 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-21-071 | Ravi Basavappa Transformative_Awards@mail.nih.gov (301) 435-7204 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Ravi Basavappa Transformative_Awards@mail.nih.gov (301) 435-7204 |
Illuminating the Druggable Genome Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Estimated Receipt Date |
|---|---|---|---|---|
| Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) | 4/15/2022 | RFA-RM-22-024 | Karlie Sharma DruggableGenome@mail.nih.gov 301-451-4965 |
Letter of Intent: 6/15/2022 Receipt Date: 7/15/2022 |
Somatic Cell Genome Editing (SCGE) Program
| Title | NIH Guide | RFA Number | NIH Contact | Receipt Date |
|---|---|---|---|---|
| Somatic Cell Genome Editing Translational Coordination and Dissemination Center (U24, Clinical Trial Not Allowed) | 4/11/2022 | RFA-RM-22-017 | Marrah Lachowicz-Scroggins marrah.lachowicz-scroggins@nih.gov 301-827-8229 |
Letter of Intent: 6/17/2022 Application Receipt Date: 7/19/2022 |
| Platform Clinical Trials of Somatic Genome Editing for Multiple Diseases (UG3/UH3, Clinical Trial Required) | 4/11/2022 | RFA-RM-22-016 | P.J. Brooks pj.brooks@mail.nih.gov 301-443-0513 |
Letter of Intent: 6/17/2022 Application Receipt Date: 7/19/2022 |
| IND-enabling Studies of Somatic Genome Editing Therapeutic Leads (U19, Clinical Trial Not allowed) | 4/11/2022 | RFA-RM-22-015 | Chris Boshoff chris.boshoff@nih.gov 301-496-1779 |
Letter of Intent: 6/17/2022 Application Receipt Date: 7/19/2022 |
| Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed) | 4/11/2022 | RFA-RM-22-014 | Betty Poon poonb@mail.nih.gov 240-669-5024 |
Letter of Intent: 6/17/2022 Application Receipt Date: 7/19/2022 |
Somatic Mosaicism across Human Tissues (SMaHT)
NIH Faculty Institutional Recruitment for Sustainable Transformation
| Title | NIH Guide | RFA Number | NIH Contact | Estimated Receipt Date |
|---|---|---|---|---|
|
|
02/17/2022 | RFA-RM-22-008 | Jessica M. Calzola FIRSTNIH@nih.gov 240-276-7474 |
Letter of Intent Receipt Date: |
Harnessing Data Science for Health Discovery and Innovation in Africa
| Title | NIH Guide | RFA Number | Common Fund Contact | Estimated Receipt Date |
|---|---|---|---|---|
| 5/27/2022 | RFA-RM-22-023 | Brad Newsome DS-IU01Mailbox@mail.nih.gov 301-451-1390 |
Letter of Intent: 8/29/2022 Receipt Dates: 9/28/2022 AIDS: 12/6/2022 |
|
| Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Research Education Program (UE5 Clinical Trial Not Allowed) | 5/27/2022 | RFA-RM-22-022 | Laura Povlich DS-IAfricaUE5@mail.nih.gov 301 827-2227 |
Letter of Intent: 8/29/2022 Receipt Dates: 9/28/2022 |
Gabriella Miller Kids First Pediatric Research Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Estimated Receipt Date |
|---|---|---|---|---|
| 11/17/2021 | RFA-RM-22-006 | James Coulombe coulombej@mail.nih.gov 301-451-1390 |
Letter of Intent: 5/10/2022 Receipt Date: 6/10/2022 |
Past Funding Opportunities
- 4D Nucleome
- Big Data to Knowledge
- Bioinformatics and Computational Biology
- Bridging Interventional Development Gaps (BrIDGs)
- Building Blocks, Biological Pathways and Networks
- Enhancing the Diversity of the NIH-Funded Workforce
- Epigenomics
- Extracellular RNA Communication
- Genotype-Tissue Expression (GTEx)
- Global Health
- Glycoscience
- Gulf Oil Spill
- HCS Research Collaboratory
- Health Economics
- High-Risk Research
- NIH Director’s Early Independence Award (EIA)
- NIH Director’s New Innovator Award
- NIH Director’s Pioneer Award
- NIH Director’s Transformative Research Awards
- Human Microbiome Project
- Illuminating the Druggable Genome
- Interdisciplinary Research
- Knockout Mouse Phenotyping
- Library of Integrated Network-Based Cellular Signatures (LINCS)
- Metabolomics
- Molecular Libraries and Imaging
- Nanomedicine
- NIH Center for Regenerative Medicine (NIH CRM)
- NIH Medical Research Scholars Program
- PROMIS: Patient-Reported Outcomes Measurement Information System
- Protein Capture Reagents
- Regulatory Science
- Science of Behavior Change
- Single Cell Analysis
- Stimulating Peripheral Activity to Relieve Conditions (SPARC)
- Strengthening the Biomedical Research Workforce
- Structural Biology
- Undiagnosed Diseases
This page last reviewed on May 27, 2022